Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody avidity and immunological memory induced by oral cholera vaccination
ISRCTN11806026Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- Sep 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cholera toxin B subunit in cholera and Enterotoxigenic Escherichia coli diarrhea (3 arms), sponsored by University of Gothenburg. Primary endpoint: Antibody avidity and immunological memory after primary vaccination and booster. Started Sep 2016; status: completed.
02
Drugs
cholera toxin B subunit
03
Conditions
choleraEnterotoxigenic Escherichia coli diarrhea
Beyond the preview
Go deeper on ISRCTN11806026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11806026.